Precision Medicine Group is a specialty services company founded in 2012 that supports pharmaceutical and life sciences clients throughout all stages of drug development and commercialization. With around 3,500 experts across 35 locations in North America, Europe, and Asia-Pacific, the company integrates science, technology, data, and human expertise to enhance the development and market access of innovative therapies.

The company operates through two main platforms: Precision for Medicine, which focuses on biomarker-driven research and development, and Precision AQ, which specializes in commercialization services. Their offerings cover the entire clinical-to-commercial continuum, including drug development, clinical trials, and market differentiation. Precision Medicine Group is guided by a leadership team with extensive experience in the biotech and pharma sectors, emphasizing core principles such as client service, accountability, and collaboration.